Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ainuovirine/Lamivudine/Tenofovir vs Efavirenz/Lamivudine/Tenofovir in HIV Patients With Active Tuberculosis
NCT07631897Phase 4Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2028
01
Overview
A Phase 4 trial of ainuovirine in human immunodeficiency virus infection (HIV). Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ainuovirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07631897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07631897.